Free Trial

Enlivex Therapeutics (ENLV) Short Interest Ratio & Short Volume

Enlivex Therapeutics logo
$0.98 -0.05 (-4.87%)
(As of 11/20/2024 ET)

Enlivex Therapeutics Short Interest Data

Enlivex Therapeutics (ENLV) has a short interest of 160,100 shares. This marks a 58.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 165,480 shares to cover all short positions.

Current Short Interest
160,100 shares
Previous Short Interest
100,900 shares
Change Vs. Previous Month
+58.67%
Dollar Volume Sold Short
$216,135.00
Short Interest Ratio
1.4 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
21,410,000 shares
Percentage of Shares Shorted
0.75%
Today's Trading Volume
388,159 shares
Average Trading Volume
165,480 shares
Today's Volume Vs. Average
235%
Short Selling Enlivex Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Enlivex Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ENLV Short Interest Over Time

ENLV Days to Cover Over Time

ENLV Percentage of Float Shorted Over Time

Enlivex Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024160,100 shares $216,135.00 +58.7%N/A1.4 $1.35
10/15/2024100,900 shares $156,395.00 -3.5%N/A1.1 $1.55
9/30/2024104,600 shares $175,728.00 -23.1%N/A1.4 $1.68
9/15/2024136,100 shares $213,677.00 +43.9%N/A1.9 $1.57
8/31/202494,600 shares $122,980.00 +26.6%N/A1.9 $1.30
8/15/202474,700 shares $91,134.00 -11.7%N/A1.3 $1.22
7/31/202484,600 shares $113,364.00 -27.4%N/A1.4 $1.34
7/15/2024116,500 shares $164,265.00 -0.6%N/A1.6 $1.41
6/30/2024117,200 shares $166,424.00 -16.8%N/A0.7 $1.42
6/15/2024140,800 shares $205,568.00 -10.5%N/A0.8 $1.46
5/31/2024157,300 shares $213,928.00 -31.8%N/A0.9 $1.36
5/15/2024230,600 shares $327,452.00 -12.4%N/A1.3 $1.42
4/30/2024263,200 shares $439,544.00 -5.6%N/A1.5 $1.67
4/15/2024278,700 shares $362,310.00 +17.9%N/A1.6 $1.30
3/31/2024236,400 shares $895,956.00 -9.6%N/A2.7 $3.79
3/15/2024261,500 shares $1.07 million +15.4%N/A2.4 $4.11
2/29/2024226,600 shares $703,593.00 +51.2%N/A2.2 $3.11
2/15/2024149,900 shares $481,179.00 -6.6%N/A1.6 $3.21
1/31/2024160,500 shares $449,400.00 -13.7%N/A1.9 $2.80
1/15/2024185,900 shares $533,533.00 +32.5%N/A2.3 $2.87
12/31/2023140,300 shares $378,810.00 +36.0%N/A1.8 $2.70
12/15/2023103,200 shares $145,512.00 -6.3%N/A1.9 $1.41
11/30/2023110,100 shares $202,584.00 -0.9%N/A3.5 $1.84
11/15/2023111,100 shares $194,425.00 -6.2%N/A3.6 $1.75
10/31/2023118,400 shares $157,472.00 +13.1%N/A3.9 $1.33
10/15/2023104,700 shares $147,627.00 -8.1%N/A4.1 $1.41
9/30/2023113,900 shares $179,962.00 +4.4%N/A4.5 $1.58
9/15/2023109,100 shares $206,199.00 +3.4%N/A4.2 $1.89
8/31/2023105,500 shares $252,145.00 -9.3%N/A4.8 $2.39
8/15/2023116,300 shares $303,543.00 +2.4%N/A5.1 $2.61
7/31/2023113,600 shares $290,816.00 +8.6%N/A4.9 $2.56
7/15/2023104,600 shares $248,948.00 +2.5%N/A4.8 $2.38
6/30/2023102,100 shares $268,247.33 -20.2%N/A3.6 $2.63
6/15/2023128,000 shares $362,240.00 +5.6%N/A3.6 $2.83
5/31/2023121,200 shares $316,332.00 -5.8%N/A3.5 $2.61
5/15/2023128,700 shares $359,073.00 -1.2%N/A3.8 $2.79
4/30/2023130,200 shares $369,768.00 -4.6%N/A3.7 $2.84
4/15/2023136,400 shares $396,924.00 -15.7%N/A3.6 $2.91
3/31/2023161,700 shares $588,588.00 +0.5%N/A4.3 $3.64
3/15/2023160,900 shares $577,631.00 -1.3%N/A5.9 $3.59
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
2/28/2023163,000 shares $652,000.00 +0.9%N/A5.7 $4.00
2/15/2023161,500 shares $673,455.00 -8.8%N/A5.5 $4.17
1/31/2023177,100 shares $775,698.00 -2.9%N/A5.8 $4.38
1/15/2023182,300 shares $796,505.16 -4.8%N/A6.9 $4.37
12/30/2022191,400 shares $753,637.50 -0.5%N/A7.8 $3.94
12/15/2022192,400 shares $779,220.00 -11.5%N/A9.2 $4.05
11/30/2022217,500 shares $996,998.25 +16.9%N/A9 $4.58
11/15/2022186,000 shares $894,660.00 +0.1%N/A6.9 $4.81
10/31/2022185,800 shares $797,082.00 -3.8%N/A6.6 $4.29
10/15/2022193,100 shares $805,227.00 +1.2%N/A5.4 $4.17
9/30/2022190,900 shares $811,325.00 +4.5%N/A4.4 $4.25
9/15/2022182,700 shares $959,175.00 -5.4%N/A3.9 $5.25
8/31/2022193,100 shares $1.01 million -7.0%N/A4.2 $5.25
8/15/2022207,700 shares $1.08 million -9.5%N/A4.4 $5.22
7/31/2022229,600 shares $975,800.00 -8.4%N/A4 $4.25
7/15/2022250,600 shares $1.23 million -9.8%N/A3.8 $4.91
6/30/2022277,700 shares $1.26 million -2.3%N/A3.5 $4.52
6/15/2022284,300 shares $1.16 million -0.3%N/A3.5 $4.07
5/31/2022285,000 shares $1.43 million -9.2%N/A3.5 $5.01
5/15/2022313,900 shares $1.34 million -9.6%N/A4.1 $4.28
4/30/2022347,200 shares $1.98 million -3.9%N/A4.7 $5.69
4/15/2022361,300 shares $2.67 million +15.0%N/A5.9 $7.39
3/31/2022314,200 shares $1.76 million -2.2%N/A5.3 $5.59
3/15/2022321,300 shares $1.63 million -10.4%N/A5.3 $5.06
2/28/2022358,500 shares $1.92 million -4.0%N/A4.9 $5.35
2/15/2022373,500 shares $1.99 million +2.8%N/A4.7 $5.34
1/31/2022363,200 shares $1.94 million +8.2%N/A4.2 $5.34
1/15/2022335,700 shares $1.97 million -8.3%N/A3.7 $5.87
12/31/2021365,900 shares $2.29 million +0.1%N/A4.2 $6.25
12/15/2021365,400 shares $2.40 million -3.6%N/A4.4 $6.56
11/30/2021379,000 shares $2.65 million +7.0%N/A5 $7.00
11/15/2021354,200 shares $2.91 million +9.9%N/A3.5 $8.21
10/29/2021322,200 shares $2.65 million +4.5%N/A1 $8.24
10/15/2021308,300 shares $2.86 million -13.0%N/A0.9 $9.28
9/30/2021354,300 shares $3.50 million -8.0%N/A1.1 $9.88
9/15/2021385,200 shares $4.21 million -8.0%N/A1.2 $10.92
8/31/2021418,500 shares $5.80 million +114.2%N/A1.3 $13.86
8/13/2021195,400 shares $1.99 million +38.0%N/A0.7 $10.17
7/30/2021141,600 shares $1.08 million No Change1.2%2.1 $7.60
7/15/2021141,600 shares $1.07 million +0.9%1.2%1.8 $7.54
6/30/2021140,400 shares $1.25 million +4.0%1.2%1.6 $8.90
6/15/2021135,000 shares $1.32 million +14.9%1.1%1.5 $9.80
5/28/2021117,500 shares $1.10 million -28.6%1.0%1.1 $9.37
5/14/2021164,500 shares $1.42 million +26.4%N/A1.1 $8.61
4/30/2021130,100 shares $1.57 million +94.2%N/A0.3 $12.10
4/15/202167,000 shares $725,610.00 -18.8%N/A0.2 $10.83
3/31/202182,500 shares $874,500.00 -17.6%N/A0.2 $10.60
3/15/2021100,100 shares $1.44 million +5.2%1.0%0.2 $14.40
2/26/202195,200 shares $1.44 million +64.4%1.1%0.2 $15.11
2/12/202157,900 shares $1.22 million -76.6%0.7%0.1 $21.09
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
1/29/2021246,900 shares $2.93 million +13.8%3.2%0.7 $11.85
1/15/2021217,000 shares $2.23 million +7.1%2.9%1 $10.29
12/31/2020202,600 shares $1.87 million -24.9%2.7%0.7 $9.22
12/15/2020269,700 shares $2.65 million +165.2%3.5%0.2 $9.83
11/30/2020101,700 shares $876,654.00 -38.2%1.3%0.1 $8.62
11/15/2020164,600 shares $1.53 million -13.1%2.2%0.1 $9.28
10/30/2020189,500 shares $2.23 million -53.7%2.5%0.2 $11.75
10/15/2020408,900 shares $5.41 million +1,497.3%5.4%0.4 $13.23
9/30/202025,600 shares $152,064.00 +22.5%0.3%0 $5.94
9/15/202020,900 shares $108,262.00 -57.1%0.3%0.3 $5.18
8/31/202048,700 shares $252,753.00 +429.4%0.6%0.5 $5.19
8/14/20209,200 shares $48,668.00 -59.1%0.1%0.1 $5.29
7/31/202022,500 shares $122,850.00 +10.3%0.3%0.2 $5.46
7/15/202020,400 shares $104,040.00 +88.9%0.3%0.2 $5.10
6/30/202010,800 shares $65,448.00 -6.1%0.1%0.1 $6.06
6/15/202011,500 shares $62,560.00 -48.0%0.2%0.1 $5.44
5/29/202022,100 shares $117,130.00 +71.3%0.3%0.2 $5.30
5/15/202012,900 shares $62,178.00 +152.9%0.2%0.1 $4.82
4/30/20205,100 shares $27,999.00 -67.1%0.1%0 $5.49
4/15/202015,500 shares $86,800.00 -17.6%0.2%0.1 $5.60
3/31/202018,800 shares $105,468.00 -69.6%0.3%0.1 $5.61
3/13/202061,900 shares $282,264.00 +302.0%1.4%0.2 $4.56
2/28/202015,400 shares $63,448.00 -54.0%0.3%0.1 $4.12
2/14/202033,500 shares $192,960.00 +805.4%0.8%0.5 $5.76
1/31/20203,700 shares $31,450.00 -32.7%0.1%0.2 $8.50
1/15/20205,500 shares $45,100.00 +10.0%0.1%0.2 $8.20
12/31/20195,000 shares $45,500.00 +11.1%0.1%0.1 $9.10

ENLV Short Interest - Frequently Asked Questions

What is Enlivex Therapeutics' current short interest?

Short interest is the volume of Enlivex Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 160,100 shares of ENLV short. Learn More on Enlivex Therapeutics' current short interest.

What is a good short interest ratio for Enlivex Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENLV shares currently have a short interest ratio of 1.0. Learn More on Enlivex Therapeutics's short interest ratio.

Is Enlivex Therapeutics' short interest increasing or decreasing?

Enlivex Therapeutics saw a increase in short interest in October. As of October 31st, there was short interest totaling 160,100 shares, an increase of 58.7% from the previous total of 100,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Enlivex Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enlivex Therapeutics: Genelux Co. (5.15%), 23andMe Holding Co. (7.86%), CASI Pharmaceuticals, Inc. (1.90%), FibroBiologics, Inc. (8.79%), PMV Pharmaceuticals, Inc. (1.94%), Oncolytics Biotech Inc. (3.65%), Ikena Oncology, Inc. (0.44%), Quince Therapeutics, Inc. (7.33%), Clearside Biomedical, Inc. (2.32%), Chimerix, Inc. (1.90%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Enlivex Therapeutics stock?

Short selling ENLV is an investing strategy that aims to generate trading profit from Enlivex Therapeutics as its price is falling. ENLV shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Enlivex Therapeutics?

A short squeeze for Enlivex Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENLV, which in turn drives the price of the stock up even further.

How often is Enlivex Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENLV, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:ENLV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners